02 January 2024
02 January 2024
Valneva’s CFO said the company is waiting to sell the voucher, which it received upon approval of its chikungunya vaccine, for €90m-€110m.
The oral suspension can be made into a 100ml solution at a 10mg/ml concentration.
FDA warns that levetiracetam and clobazam can cause DRESS, a rare hypersensitivity reaction which can be life threatening if not treated quickly.
PYC will receive A$4.5m in upfront payments from the partners to access its data sets and capabilities.
Preclinical development of the drug is anticipated to commence earlier next year.
J&J has acquired a global license for South Korean LegoChem’s ADC for $100m upfront along with milestone-based payments and tiered royalties on sales.
Elpiscience is entitled to receive more than $1.7bn in milestone payments from Astellas.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest thematic report will help you to understand and identify the important themes that threaten to disrupt your business in 2024. Our 2024 theme map covers not only disruptive tech themes but also ESG, macroeconomic, and regulatory themes. Reading this report is the first step towards making better business decisions in 2024.
Give your business an edge with our leading industry insights.
